NEW YORK – The US Food and Drug Administration on Monday issued new guidance for SARS-CoV-2 test developers to evaluate the potential impact of viral mutations on the tests.
NEW YORK – The US Food and Drug Administration on Monday issued new guidance for SARS-CoV-2 test developers to evaluate the potential impact of viral mutations on the tests.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.